Home IndicesNIFTY PHARMA

NIFTY Pharma

NIFTY PHARMA Share Price

Buy Sell

23,840.90

-329.55 (-1.36%) loss

as on 12 May 2026 at 18:471D

NSE

Open24,177.30

52W High24,310.80

52W Low20,576.05

NIFTY Pharma

NIFTY PHARMA Share Price

23,840.90

-329.55 (-1.36%) loss

as on 12 May 2026 at 18:471D

NSE

Overview

News

Company Holdings

Sector Weightage

History

Past Returns

Comparison

Performers

Top Funds

Top ETFs

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

Use Chart

NIFTY PHARMA Stock Performance

Markets Today

High

24,185.45

Low

23,816.40

Open at

24,177.30

Prev Close

24,170.45

Volumes

Avg Price

0.00

Lower Circuit

0.00

Upper Circuit

0.00

Last Traded Details

Quantity

Time

18:47:19

Price Movement

23,816.4024,185.45

0.10%

down side

up side

1.42%

Historical Performance

3 M High

24,310.80

3 M Low

21,149.90

1 Yr High

24,310.80

1 Yr Low

20,576.05

3 Yr High

24,310.80

3 Yr Low

12,040.65

5 Yr High

24,310.80

5 Yr Low

11,542.45

1-Year Performance

20,576.0524,310.80

15.87%

down side

up side

1.93%

Market Insights

Positive Stocks

Negative Stocks

Neutral Stocks

NIFTY PHARMA Latest News

NIFTY PHARMA Technicals

Moving Averages

Classic

Exponential

Period	Simple	Signal
5-SMA	00	Bullish
10-SMA	00	Bullish
20-SMA	00	Bullish
50-SMA	00	Bullish
100-SMA	00	Bullish
200-SMA	00	Bullish

Technical Indicators

Indicator	Value	Action
RSI(14)	00	Bullish
ATR(14)	00	Bullish
STOCH(14)	00	Bullish
STOCH RSI(14)	00	Bullish
MACD(12,26)	00	Bullish
ADX(14)	00	Bullish

Summary of Technical Indicators for NIFTY PHARMA

NIFTY PHARMA Companies

Gainers

Losers

Sorry, No Data Available at this Moment!

View In-Depth

Sector Weightage

Sectors	Companies	Weightage	Market Cap (Cr.)
Healthcare	20	100.00%	18,70,112.19

View In-Depth

NIFTY PHARMA Share Price History

View In-Depth

NIFTY PHARMA Historical Returns

Sorry, No Data Available at this Moment!

NIFTY PHARMA Investment Returns

Short Term

1 Week

1.15%

1 Month

7.88%

3 Month

6.5%

6 Month

5.52%

9 Month

9.6%

Long Term

1 Year

12.98%

2 Years

25.88%

3 Years

90.93%

4 Years

91.89%

5 Years

69.5%

In Short Term
In Long term

1 Week

1.15%

1 Month

7.88%

3 Month

6.5%

6 Month

5.52%

9 Month

9.6%

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.

Start SIP

NIFTY PHARMA Comparison

Broad Based Indices

Sectoral Indices

Sorry, No Data Available at this Moment!

NIFTY PHARMA Performers

Sorry, No Data Available at this Moment!

About NIFTY Pharma

The Nifty Pharma Index is a sectoral index on the National Stock Exchange (NSE) that tracks the performance of 20 leading pharmaceutical companies listed in India. Launched on July 1, 2005, with a base date of January 1, 2001, the index offers investors and analysts a focused view of the Indian pharmaceutical sector. It features some of the largest and most liquid pharma stocks that play a crucial role in both domestic and international healthcare markets. The index helps monitor how the sector responds to factors like regulatory changes, drug approvals, global demand shifts, and currency movements.

What is NIFTY Pharma Based On?

Nifty Pharma is calculated using the free-float market capitalization method, meaning only publicly tradable shares (excluding promoter-held and locked-in shares) are considered. The index value reflects the total free-float market capitalization of its 20 constituent stocks relative to a fixed base market capitalization. This approach ensures the index accurately represents the investable portion of the pharma sector and captures its real-time market movements.

Selection Criteria for Stocks in NIFTY Pharma

Stocks included in the Nifty Pharma Index must meet the following conditions:

Companies must be part of the Nifty 500 at the time of review. If fewer than 20 eligible pharma stocks are available, additional companies are chosen from the top 800 based on market capitalization and turnover.
Only companies classified under the pharmaceutical sector are considered for inclusion.
Stocks must have traded on at least 90% of trading days over the past six months and should have a minimum listing history of one month.
The final list of 20 stocks is selected based on free-float market capitalization, with preference given to those available in the NSE Futures & Options segment.
To ensure diversification, no single stock can have a weight exceeding 33%, and the combined weight of the top three stocks cannot exceed 62% at the time of rebalancing.

How Often Do Stocks in NIFTY Pharma Change?

The Nifty Pharma Index is reviewed and rebalanced semi-annually, with cut-off dates on January 31 and July 31 each year. The review process uses average data from the preceding six months to determine stock eligibility and rankings. Any changes to the index composition are announced at least four weeks in advance and are implemented on the last trading day of March and September.

Who Maintains the NIFTY Pharma Index?

The Nifty Pharma Index is owned and managed by NSE Indices Limited, which is a part of the National Stock Exchange of India. NSE Indices handles the index calculation, periodic reviews, and data dissemination. A dedicated committee oversees the index methodology, ensuring transparency, fairness, and alignment with global standards.

What NIFTY Pharma Tells Us?

The Nifty Pharma Index reflects the performance and sentiment of India’s pharmaceutical sector. Its movements give investors an idea of how major pharma companies are performing in response to regulatory changes, export demand, global healthcare trends, and domestic drug sales.

A rising Nifty Pharma often indicates strong earnings, favourable government policies, or increased global demand for Indian medicines. On the other hand, a decline may signal pricing pressures, regulatory hurdles, or global health uncertainties. It serves as a key sectoral indicator for investors tracking the healthcare and pharma industry.

Is NIFTY Pharma a Benchmark?

Nifty Pharma is a widely recognized benchmark for India’s pharmaceutical sector. It tracks the performance of top pharmaceutical companies listed on the National Stock Exchange, offering insight into sector trends and investment returns. The index’s methodology and composition provide a reliable basis for comparing pharma-focused mutual funds, ETFs, and other investment products. It is closely followed by sectoral ETFs and used by analysts, fund managers, and investors to evaluate the health and growth potential of the Indian pharma industry.

NIFTY PHARMA Mutual Funds

NIFTY PHARMA ETF

NSE Indices Today

Index Name	Price

View All

BSE Indices Today

Index Name	Price

View All

Top Gainers Today

Stock Name	Price

View All

Top Losers Today

Stock Name	Price

View All

Open IPOs

View All IPOs

FAQs on NIFTY PHARMA

How many companies are in NIFTY Pharma?

There are 20 companies in NIFTY Pharma as on 12 May 2026 at 18:47.

What is the NIFTY Pharma share price today?

The current price of NIFTY Pharma is ₹23,840.90 as on 12 May 2026 at 18:47.

What are the historical returns of NIFTY Pharma?

The past returns of NIFTY Pharma as on 12 May 2026 at 18:47 are -

Past 1 year: 12.98%
Past 3 years: 90.93%
Past 5 years: 69.50%

What is the market capitalization of NIFTY Pharma?

The cumulative market capitalization of all the companies listed in NIFTY Pharma stands at ₹ 18,70,112.19 Cr. as on 12 May 2026 at 18:47.

Can you buy NIFTY Pharma directly?

No, you cannot buy NIFTY Pharma directly. However, you can trade futures and options of 5 NSE Indices (NIFTY, BANKNIFTY, FINNIFTY, MIDCPNIFTY and NIFTY NEXT 50) and 2 BSE Indices (BSE Sensex and BSE Bankex) at the moment.

Is it possible to purchase the stocks of NIFTY Pharma?

Yes, you can individually purchase the stocks of NIFTY Pharma on Dhan using Dhan trading app or web trading platform.

How to buy the stocks of NIFTY Pharma on Dhan?

You can purchase the stocks of NIFTY Pharma using Dhan's demat account. Follow the below steps if you are new to Dhan -

Download the Dhan App to open a Open Demat Account
Navigate to the “Money Tab”
Add money to your account
Search for the stock you want to buy
Tap on “Buy”.

Invest in
NIFTY PHARMA

Pay Zero Brokerage on Delivery

Open FREE Demat Account

+91

error

Or Scan the QR Code to download the Dhan App

Explore | Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

We are doing so by giving you access to not just one but 6 products within the Dhan ecosystem:

Dhan App: The only online trading app you need for buying and selling equity, futures, options, commodity, and currency.
Dhan Web: Trade on the big screen across segments with our web trading platform.
Options Trader App: A dedicated option trading app built for India's F&O traders.
Options Trader Web: Love big screens and F&O trading? Use our web option trading platform.
Dhan + TradingView: The magic of Tradingview charts for free with the Lightning-Fast experience of Dhan on tv.dhan.co.
Connect to TradingView: Our Tradingview broker integration allows you to trade in Stocks, Futures, and Commodities directly from tradingview.com via Dhan.

This means that with Dhan, you'll be able to start:

Lakhs of users already trust Dhan for their online stock trading and investing needs. Dhan is growing rapidly because of the love we receive from SuperTraders and Long-Term Investors who acknowledge that the platform is innovating for them, building super useful features that help them do everything from investing in stock market to trading F&O like a pro on the Tradingview charts and much more.

While we are growing, we will always remember why we started building in the first place - you. Our user-first approach will always be at the heart of our philosophy. Come join us on this incredible journey!

Try it out, you can close your account at anytime using this link.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.

Details of client bank account

For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.

Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.

DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.

Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.

Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit

Attention investors:

Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.

Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.

Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.

Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/

Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX

Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets